UnitedHealth Stock Sell-Off Screams 'Buying Opportunity'

Core Viewpoint - The decline in UnitedHealth Group, Inc. shares is viewed as a buying opportunity by Cantor Fitzgerald analysts following a significant 20% drop in stock price [1] Group 1: Stock Performance - UnitedHealth stock experienced a sharp decline after a disappointing 2027 Medicare Advantage Advance Notice and a fourth quarter earnings report that indicated a rare revenue decline for the upcoming year [1] - Following the drop, UnitedHealth shares made a slight recovery, gaining 3.86% to trade at $293.62 [2] Group 2: Analyst Ratings and Outlook - Cantor Fitzgerald maintained an Overweight rating and a price target of $440 for UnitedHealth Group, contrasting with other analysts who lowered their price targets [2] - The firm's bullish outlook is supported by valuation and overall market conditions despite the recent heavy selling [2]